Fingerprint
Dive into the research topics of 'First-in-human phase I/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
First-in-human phase I/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction
Morie A. Gertz, Heather Landau, Raymond L. Comenzo, David Seldin, Brendan Weiss, Jeffrey Zonder, Giampaolo Merlini, Stefan Schönland, Jackie Walling, Gene G. Kinney, Martin Koller, Dale B. Schenk, Spencer D. Guthrie, Michaela Liedtke
Research output: Contribution to journal › Article › peer-review
121
Scopus
citations